Stock Price
14.31
Daily Change
-6.84%
Yearly
-49.79%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 136.78 0.91 0.67% 21.93%
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Aerie Pharmaceuticals 7.49 -0.06 -0.79% -50.30%
ALKERMES 25.22 -0.03 -0.12% 10.37%
Antares Pharma 3.43 -0.14 -3.92% -21.33%
BioDelivery Sciences International 3.00 -0.06 -1.96% -30.23%
Bristol-Myers Squibb 64.89 -0.04 -0.06% -2.77%
Cara Therapeutics 11.54 -0.41 -3.43% -42.50%
Coherus Biosciences 13.23 -0.67 -4.82% -26.62%
Endo International Ordinary Shares 3.34 0.07 2.14% -52.69%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
GW Pharmaceuticals 218.96 0 0% 108.53%
Horizon Pharma 88.20 -2.90 -3.18% 8.62%
Jazz Pharmaceuticals 142.75 -1.61 -1.12% -14.52%
J&J 167.10 -0.74 -0.44% 2.65%
Eli Lilly 247.07 2.95 1.21% 24.48%
Merck & Co 81.54 0.16 0.20% -1.98%
Neurocrine Biosciences 74.50 -3.86 -4.93% -31.51%
Pacira 63.88 -0.20 -0.31% -13.50%
P&G 156.73 -3.08 -1.93% 17.31%
Revance Therapeutics 14.31 -1.05 -6.84% -49.79%
Supernus Pharmaceuticals 29.25 -1.11 -3.66% -1.68%
Teva Pharmaceutical Industries 8.89 -0.28 -3.05% -29.16%
Zogenix 15.64 -0.29 -1.82% -14.37%

Indexes Price Day Year
NASDAQ 14507 -386.86 -2.60% 9.92%
US2000 2096 -66.23 -3.06% -2.55%

Revance Therapeutics
Revance Therapeutics, Inc. is a biotechnology company that is focused on aesthetic and therapeutic offerings, including neuromodulator product, DaxibotulinumtoxinA for Injection. The DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with purified botulinum toxin that does not contain human or animal-based components. The Company is also evaluating DaxibotulinumtoxinA for Injection in the full upper face, including glabellar lines, forehead lines, and crow’s feet, as well as in two therapeutic indications cervical dystonia and adult upper limb spasticity. It offers products and services for United States aesthetics practices, including the resilient hyaluronic acid (RHA) Collection of dermal fillers and HintMD fintech platform. The RHA Collection of dermal fillers is a filler for the correction of dynamic facial wrinkles and folds. HintMD fintech platform includes integrated smart payment, subscription, and loyalty digital services.